BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,188 | -62.0% | 39,600 | 0.0% | 0.00% | -60.0% |
| Q2 2023 | $263,736 | -61.8% | 39,600 | +7.0% | 0.01% | -61.5% |
| Q1 2023 | $690,420 | -18.4% | 37,000 | -6.1% | 0.01% | -18.8% |
| Q4 2022 | $846,312 | +149.6% | 39,400 | +37.5% | 0.02% | +128.6% |
| Q3 2022 | $339,000 | -18.3% | 28,650 | -8.9% | 0.01% | -12.5% |
| Q2 2022 | $415,000 | +6.1% | 31,450 | +68.2% | 0.01% | +33.3% |
| Q1 2022 | $391,000 | +10.5% | 18,700 | +7.5% | 0.01% | +20.0% |
| Q4 2021 | $354,000 | -35.9% | 17,400 | -4.4% | 0.01% | -37.5% |
| Q3 2021 | $552,000 | -3.5% | 18,200 | -7.6% | 0.01% | 0.0% |
| Q2 2021 | $572,000 | -8.9% | 19,700 | +35.4% | 0.01% | -20.0% |
| Q1 2021 | $628,000 | +166.1% | 14,550 | +185.3% | 0.01% | +150.0% |
| Q4 2020 | $236,000 | +15.7% | 5,100 | +8.5% | 0.00% | 0.0% |
| Q3 2020 | $204,000 | – | 4,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |